Tropisetron
- 1 November 1993
- journal article
- research article
- Published by Springer Nature in Drugs
- Vol. 46 (5) , 925-943
- https://doi.org/10.2165/00003495-199346050-00009
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- The 5-hydroxytryptamine receptor antagonists as antiemetics: Preclinical evaluation and mechanism of actionEuropean Journal Of Cancer, 1993
- Prevention of emesis by ics 205-930 in children receiving cytotoxic chemotherapyEuropean Journal Of Cancer, 1993
- Compassionate Use of a 5-HT3-Receptor Antagonist, Tropisetron, in Patients Refractory to Standard Antiemetic TreatmentDrugs, 1992
- TropisetronDrugs, 1992
- Three Yearsʼ Experience with Tropisetron in the Control of Nausea and Vomiting in Cisplatin-Treated PatientsDrugs, 1992
- 5-HT3 Receptor AntagonistsDrugs, 1991
- The effect of three dose levels of ICS 205–930 (a selective 5HT-3 antagonist) on cisplatin-induced nausea and vomitingEuropean Journal of Cancer and Clinical Oncology, 1989
- Antiarrhythmic effect of a 5-hydroxytryptamine M-receptor antagonist, ICS 205-930The American Journal of Cardiology, 1988
- Extrapyramidal Reactions with High-Dose MetoclopramideNew England Journal of Medicine, 1983
- Antiemetic Efficacy of High-Dose Metoclopramide: Randomized Trials with Placebo and Prochlorperazine in Patients with Chemotherapy-Induced Nausea and VomitingNew England Journal of Medicine, 1981